The Estée Lauder Companies Invests in 111Skin
The Estée Lauder Companies is doubling down on high-performance skincare with its latest strategic move, acquiring a minority stake in 111Skin. The London-based label, founded in 2012 by Dr. Yannis Alexandrides and Eva Alexandrides, has built a cult following for its clinically inspired, results-driven formulas. Financial terms of the deal were not disclosed.
The investment arrives at a pivotal moment for Lauder, as the company continues to reshape its portfolio while reportedly exploring a potential merger with Puig—a move that could create a powerhouse exceeding $20 billion in annual revenue. At the same time, the company is sharpening its focus on skincare innovation and global expansion.
Rather than chasing scale alone, Lauder’s recent strategy reflects a more targeted approach—identifying brands that fill key gaps across regions and categories. Recent moves include investments in Xinú and a full acquisition of Forest Essentials, reinforcing its commitment to culturally rooted, high-growth beauty segments.
“Skincare is entering a new era,” said Stéphane de La Faverie, pointing to the growing demand for treatment-level results and longevity-focused beauty. “111Skin embodies this evolution—bridging clinical expertise with next-generation formulations.”
At the core of 111Skin’s appeal is its origin story. Developed alongside Dr. Alexandrides’ surgical practice on 111 Harley Street, the brand merges aesthetic medicine with luxury skincare. Its proprietary complexes and treatment-inspired approach have positioned it at the intersection of science, beauty, and wellness—one of the fastest-growing spaces in the industry.
Digital growth is also a key driver. Direct-to-consumer sales account for roughly 20 percent of the brand’s business, while North America leads as its largest market, contributing about 40 percent of overall sales. Other strong regions include China, the U.K., Europe, and Asia-Pacific, with estimated annual revenues between $40 million and $50 million.
For 111Skin, the partnership signals acceleration without compromise. “We are thrilled to partner with The Estée Lauder Companies and enter this exciting new chapter,” said the founders, alongside CEO Vanessa Goddevrind, who emphasized plans to build on the brand’s global momentum.
The deal also underscores broader shifts within Lauder’s portfolio. As skincare takes center stage, the company is reportedly reevaluating parts of its color cosmetics business, including potential changes involving Too Faced, Smashbox, and Bobbi Brown.
With this latest investment, Lauder is making one thing clear: the future of beauty is clinical, results-driven—and deeply rooted in skincare.
Photo Credit: 111Skin
